Skip to content
Open access

Perforin triggers iron-induced mitochondrial damage to drive ferroptosis and anti-tumor immunity.

Oct 2026 · Cell · 0 citations · 103 references
Medicine

TL;DR

A Gzm-independent function of Prf1 is defined as a direct executioner of cancer cell death through ferroptosis, an iron- and lipid-dependent form of cell death in patients with cancer.

Abstract

Cytotoxic CD8+ T cells and natural killer cells are critical effectors of anti-tumor immunity. Cytotoxic lymphocytes eliminate tumor cells by releasing perforin (Prf1), a pore-forming protein that enables granzymes (Gzms) to enter target cells and trigger both caspase-dependent and -independent cell death. Here, we uncover a previously unrecognized, Gzm-independent function of Prf1. We find that Prf1 directly induces tumoral ferroptosis, an iron- and lipid-dependent form of cell death. Mechanistically, Prf1-mediated pore formation drives endocytosis of the transferrin receptor, which increases cellular iron uptake. Prf1 promotes the formation of endosomal-mitochondrial contacts, which leads to mitochondrial iron accumulation, mitochondrial dysfunction, and tumor cell ferroptosis. Dietary iron supplementation suppresses tumor progression in murine tumor models in a Prf1-dependent manner. Higher Prf1 expression correlates with improved survival and enhanced response to immune checkpoint blockade in patients with cancer. These findings define a Gzm-independent function of Prf1 as a direct executioner of cancer cell death through ferroptosis.

Read PDF

Similar papers

Open access Oct 2026

Macrophage-induced ferritin expression protects pancreatic cancer cells from ferroptosis.

Reactive oxygen species (ROS) drive pro-tumorigenic signaling but also promote lipid peroxidation and ferroptosis, making ROS regulation critical during high oxidative stress stages of tumor progression, such as metastasis. Loss of the antioxidant TIGAR in pancreatic ductal adenocarcinoma (PDAC) cells raises ROS and en...

Eric C. Cheung, Meng-Han Wu, Wen-Chih Cheng et al. · 1 citation
Review Open access Oct 2026

Inflammatory cell death in cancer: linking pyroptosis, necroptosis, ferroptosis, PANoptosis, and antitumor immunity

It is proposed that future cancer therapy should move beyond simply inducing tumor cell death toward designing immune-productive death programs that are spatially controlled, cell-type selective, and rationally synchronized with immunotherapy.

Shan-Shan Li, Zi-Han Zhou, Peng-Hao Li et al. · 0 citations
Review Open access Oct 2026

Ferroptosis in the tumor immune microenvironment: from danger signals to immune reprogramming

Immune-checkpoint blockade has changed cancer therapy, yet durable responses remain limited by immune exclusion, myeloid suppression and metabolic adaptation within the tumor immune microenvironment. Ferroptosis, an iron-dependent form of lipid-peroxidation-driven regulated cell death, offers a mechanistic bridge betwe...

Qing-Miao Shi, Bing-Qian Tan, Hui-Wu Xing · 0 citations
Review Open access 2026

Tumor but not tumor cells: Ferroptosis in non-tumor cells within the tumor

Ferroptosis is an iron-dependent form of regulated cell death that has attracted considerable attention as a promising therapeutic strategy because of its ability to eliminate tumor cells. However, tumors are multicellular ecosystems in which malignant cells coexist with diverse stromal and immune cell populations that...

Liang Gong, Zhi-Cheng Gong, Kang Wang et al. · 0 citations
Review Open access Sep 2026

Neutrophil Extracellular Traps in the Tumor Microenvironment: Mechanisms, Immune Regulation, and Implications for Immune Checkpoint Inhibitor Therapy

Neutrophil extracellular trap formation (NETosis) has emerged as a pivotal regulator of the tumor immune microenvironment and a key determinant of response to cancer immunotherapy. NETs—web-like chromatin fibers decorated with histones, citrullinated histone H3, myeloperoxidase, neutrophil elastase, and matrix metallop...

Chung-Wen Kuo, H. Chiou, Shih-Yu Huang et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.